Explore PACK EXPO insights here
Discover a taste of the PACK EXPO highlights, live from the show floor!
Subscribe
Design & Materials
Sustainability
Machinery
Logistics
Industry News
Downloads
Home
Supplier News
Supplier News
The latest supplier news from Healthcare Packaging
Home
H.B. Fuller Hires Michael Olejnik to Expand Flexible Packaging Team
H.B. Fuller Company continues to demonstrate its commitment to the flexible packaging industry with the addition of Michael Olejnik as business development manager. Olejnik brings more than 25 years of flexible packaging knowledge and experience to H.B. Fuller. Olejnik held positions in sales and marketing management at Exopack Canada and Genpak. He also worked for Mobil Chemical and BI-AX International, where he developed strategic laminations instrumental in developing business for key packaging customers.
January 10, 2011
Home
Colorpak signs sale agreement to acquire Carter Holt Harey's folding carton business
Colorpak Limited (Colorpak) announces that it has completed due diligence and signed relevant agreements with Carter Holt Harvey (βCHHβ) for the purchase of the folding carton businesses conducted at Reservoir and Mount Waverley in Victoria, Villawood in NSW and Auckland in New Zealand for a total consideration of AUD $5.0 million.
January 7, 2011
Regulatory
November 2010 Safety Labeling Changes: 37 Medical Product Labels with changes to Warnings, Contraindications, Precautions, Adverse Reactions
The MedWatch November 2010 Safety Labeling Changes posting includes 37 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.
December 30, 2010
Home
Merck Names Keller Crescent 'Supplier of the Year'
Merck, Las Piedras, Puerto Rico, has selected Keller Crescent as a 2010 Supplier of the Year.
December 28, 2010
Regulatory
Man Up Now Capsules: Consumer Warning - Undeclared Drug Ingredient
FDA warned consumers not to use Man Up Now capsules, marketed as a dietary supplement for sexual enhancement, because FDA analysis determined that the product contains sulfoaildenafil, a chemical similar to sildenafil, the active ingredient in Viagra. Like sildenafil, this chemical may interact with prescription drugs such as nitrates, including nitroglycerin, and cause dangerously low blood pressure.
December 15, 2010
Nutraceuticals/Dietary
Reese Pharmaceutical Company OTC Products: Recall - Mislabeled Guaifenesin Tablets
Refenesen Expectorant (guaifenesin 200 mg tablets) Select Brand Mucus Relief Expectorant (guaifenesin 200 mg) QC Medifin Expectorant (guaifenesin 200 mg) Leader Cough Tabs Expectorant (guaifenesin 200 mg)
December 15, 2010
Home
Merck Names Keller Crescent 'Supplier of the Year'
Merck, Las Piedras, Puerto Rico, has selected Keller Crescent as a 2010 Supplier of the Year.
December 14, 2010
Regulatory
B. Braun addEASE Binary Connector: Class I Recall -Stopper Fragments May Enter Bag
When the addEASE binary connector is inserted into a partial additive bag (PAB) stopper, fragments of the stopper may enter the bag, resulting in a small amount of visible particles in the solution.
December 1, 2010
Regulatory
October 2010 Safety Labeling Changes: 34 Medical Product Labels with changes to Boxed Warnings, Contraindications, Precautions, Adverse Reactions
The MedWatch October 2010 Safety Labeling Changes posting includes 34 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.
November 29, 2010
Regulatory
MOCON receives Packaging World's leader in packaging honor
MOCON, Inc. has just received a leadership honor from Packaging World magazine in the inspection/testing category.
October 27, 2010
Home
Bemis Wins 2010 Leadership in Packaging Award For Flexible Packaging
Bemis Company has won the Packaging World Leadership in Packaging award for 2010.
October 27, 2010
Regulatory
GnRH Agonists: Label Change - Increased Risk of Diabetes and Cardiovascular Disease
Gonadotropin-Releasing Hormone (GnRH) agonists will have new safety information added to the Warnings and Precautions section of the drug labels.
October 27, 2010
Materials
Catalent receives award for its innovative combination potent product launch partnership with a top 5 multi-national pharma company
Catalent Pharma Solutions has won for the third year in a row "The Best Contract Manufacturing Project" award at the 2010 European Outsourcing Awards, again recognizing its industry leadership and excellence.
October 27, 2010
Regulatory
September 2010 Safety Labeling Changes: 37Medical Product Labels with changes to Warnings, Contraindications,Precautions, Adverse Reactions
The MedWatch September 2010 Safety Labeling Changes posting includes 37 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.
October 21, 2010
Regulatory
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
FDA notified healthcare professionals of new risk information added to the Warnings and Precautions, Contraindications, and Clinical Pharmacology sections of the antiviral drug Invirase (saquinavir), describing a potential change in the electrical activity of the heart when Invirase is used with another antiviral medication, Norvir (ritonavir).
October 21, 2010
Home
Keystone Folding Box Company installs new equipment and technologies to better serve its growing commercial business
Wade Hartman, President of The Keystone Folding Box Company, a New Jersey-based provider of paperboard solutions, announced today that the company recently completed a multi-year initiative to invest in new capital equipment and packaging technologies in order to meet the growing needs of its commercial business.
October 15, 2010
Home
Keystone Folding Box Company Completes Multi-Year Capital Investment
Wade Hartman, President of The Keystone Folding Box Company, a New Jersey-based provider of paperboard solutions, announced today that the company recently completed a multi-year initiative to invest in new capital equipment and packaging technologies in order to meet the growing needs of its commercial business.
October 6, 2010
Regulatory
FDA MedWatch - Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials
Amgen and FDA notified healthcare professionals that certain lots of Epogen and Procrit (Epoetin alfa) vials are being recalled as a precaution, because the vials may contain extremely thin glass flakes (lamellae) that are barely visible.
September 30, 2010
Previous Page
Page 85 of 88
Next Page